『The $26 million hair growth injectable that started with a hairy mole — Amplifica's osteopontin discovery, the Phase 1 results, and what Eli Lilly's participation signals.』のカバーアート

The $26 million hair growth injectable that started with a hairy mole — Amplifica's osteopontin discovery, the Phase 1 results, and what Eli Lilly's participation signals.

The $26 million hair growth injectable that started with a hairy mole — Amplifica's osteopontin discovery, the Phase 1 results, and what Eli Lilly's participation signals.

無料で聴く

ポッドキャストの詳細を見る
From Root to Ritual by Laritelle Organic. In brief: Amplifica Holdings Group closed an oversubscribed $26 million Series B financing on August 12, 2026 — with Eli Lilly and Company participating as a strategic investor. The company is clinical-stage, spun out of UC Irvine, and built on a discovery by Professor Maksim Plikus: senescent pigment cells in hairy moles produce osteopontin, a signalling molecule that reactivates dormant hair fol... Read the full article: https://laritelleorganic.com/blogs/from-root-to-ritual/the-26-million-hair-growth-injectable-that-started-with-a-hairy-mole-amplificas-osteopontin-discovery-the-phase-1-results-and-what-eli-lillys-participation-signals
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません